Evidence map›Paper›PMID 35802735›Full record

ArticlePloS one2022

Dissemination of carbapenemase-producing Enterobacterales in the community of Rawalpindi, Pakistan.

Amina Habib, Stéphane Lo, Khanh Villageois-Tran, Marie Petitjean, Shaheen Akhtar Malik, Laurence Armand-Lefèvre, Etienne Ruppé, Rabaab Zahra

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Molecular characterization of blaBMC infectious diseases · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Emergence of Carbapenem-Resistant UropathogenicPathogens (Basel, Switzerland) · 2024
    Article
  10. Article
  11. Article
  12. Predominance ofMedicina (Kaunas, Lithuania) · 2024
    Article
  13. Article
  14. Lessons from a global antimicrobial resistance surveillance network.Bulletin of the World Health Organization · 2023
    Article
  15. Article
  16. Article
  17. Review
  18. High Occurrence of Multidrug-ResistantAntibiotics (Basel, Switzerland) · 2022
    Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Amina HabibDepartment of Microbiology, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, Pakistan.
Stéphane LoUniversité de Paris, IAME, INSERM, Paris, France.
Khanh Villageois-TranUniversité de Paris, IAME, INSERM, Paris, France.
Marie PetitjeanUniversité de Paris, IAME, INSERM, Paris, France.
Shaheen Akhtar MalikAccident and Emergency Department, Benazir Bhutto Hospital, Rawalpindi, Pakistan.
Laurence Armand-LefèvreUniversité de Paris, IAME, INSERM, Paris, France.
Etienne RuppéUniversité de Paris, IAME, INSERM, Paris, France.
Rabaab ZahraDepartment of Microbiology, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, Pakistan.ORCID 0000-0001-8784-0114
Inserm · FRQuaid-i-Azam University · PKBenazir Bhutto Hospital · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Carbapenems are considered last-line beta-lactams for the treatment of infections caused by multidrug-resistant Gram-negative bacteria. However, their activity is compromised by the rising prevalence of carbapenemase-producing Enterobacterales (CPE), which are especially marked in the Indian subcontinent. In Pakistan, previous reports have warned about the possible spread of CPE in the community, but data are still partial. This study was carried out to analyse the prevalence of CPE, the genetic characterisation, and phylogenetic links among the spreading CPE in the community. In this cohort study, we collected 306 rectal swabs from patients visiting Benazir Bhutto hospital, Rawalpindi. CPEs were screened by using ertapenem-supplemented MacConkey agar. Identification was performed by using conventional biochemical tests, and genomes were sequenced using Illumina chemistry. Antibiotic resistance genes, plasmid incompatibility groups, and Escherichia coli phylogroups were determined in silico. Sequence types were determined by using MLST tool. The prevalence of CPE carriage observed was 14.4% (44/306 samples). The most common carbapenemase-encoding gene was bla-NDM-5 (n = 58) followed by blaNDM-1 (n = 7), blaNDM (non-assigned variant, n = 4), blaOXA-181 (n = 3), blaOXA-232 (n = 3) and blaNDM-7 (n = 1). Most of the CPE were E. coli (55/64, 86%), and the genomic analysis revealed a pauciclonal diffusion of E. coli with ST167 (n = 14), 405 (n = 10), 940 (n = 8), 648 (n = 6) and 617 (n = 5). We obtained a second sample from 94 patients during their hospital stay in whom carriage was negative at admission and found that 7 (7.4%) acquired a CPE. Our results indicate that the prevalence of CPE carriage in the Pakistani urban community was high and driven by the dissemination of some E. coli clones, with ST167 being the most frequent. The high CPE carriage in the community poses a serious public health threat and calls for implementation of adequate preventive measures.

Indexed as

EnterobacteriaceaeEnterobacteriaceae InfectionsEscherichia coliAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesCohort StudiesHumansMicrobial Sensitivity TestsMultilocus Sequence TypingPakistanPhylogenyAnti-Bacterial AgentsBacterial Proteinsbeta-Lactamasescarbapenemase

Identifiers

PMID35802735
PMCPMC9269877
OpenAlexW4284971278

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.